Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Whole-Genome Sequencing to Differentiate Relapse From Reinfection in Community-Onset Bacteremic Acinetobacter baumannii Pneumonia.

Meumann EM, Anstey NM, Currie BJ, Piera KA, Baird R, Sarovich DS, Davis JS.

Open Forum Infect Dis. 2019 Jun 1;6(7):ofz263. doi: 10.1093/ofid/ofz263. eCollection 2019 Jul.

2.

Genomic epidemiology of severe community-onset Acinetobacter baumannii infection.

Meumann EM, Anstey NM, Currie BJ, Piera KA, Kenyon JJ, Hall RM, Davis JS, Sarovich DS.

Microb Genom. 2019 Mar;5(3). doi: 10.1099/mgen.0.000258. Epub 2019 Feb 26.

3.

Plasmodium falciparum artemisinin resistance monitoring in Sabah, Malaysia: in vivo therapeutic efficacy and kelch13 molecular marker surveillance.

Grigg MJ, William T, Piera KA, Rajahram GS, Jelip J, Aziz A, Menon J, Marfurt J, Price RN, Auburn S, Barber BE, Yeo TW, Anstey NM.

Malar J. 2018 Dec 10;17(1):463. doi: 10.1186/s12936-018-2593-x.

4.

Plasmodium falciparum Activates CD16+ Dendritic Cells to Produce Tumor Necrosis Factor and Interleukin-10 in Subpatent Malaria.

Loughland JR, Woodberry T, Boyle MJ, Tipping PE, Piera KA, Amante FH, Kenangalem E, Price RN, Engwerda CR, Anstey NM, McCarthy JS, Minigo G.

J Infect Dis. 2019 Jan 29;219(4):660-671. doi: 10.1093/infdis/jiy555.

5.

Platelets kill circulating parasites of all major Plasmodium species in human malaria.

Kho S, Barber BE, Johar E, Andries B, Poespoprodjo JR, Kenangalem E, Piera KA, Ehmann A, Price RN, William T, Woodberry T, Foote S, Minigo G, Yeo TW, Grigg MJ, Anstey NM, McMorran BJ.

Blood. 2018 Sep 20;132(12):1332-1344. doi: 10.1182/blood-2018-05-849307. Epub 2018 Jul 19.

6.

Intravascular haemolysis in severe Plasmodium knowlesi malaria: association with endothelial activation, microvascular dysfunction, and acute kidney injury.

Barber BE, Grigg MJ, Piera KA, William T, Cooper DJ, Plewes K, Dondorp AM, Yeo TW, Anstey NM.

Emerg Microbes Infect. 2018 Jun 6;7(1):106. doi: 10.1038/s41426-018-0105-2.

7.

The effect of regularly dosed paracetamol versus no paracetamol on renal function in Plasmodium knowlesi malaria (PACKNOW): study protocol for a randomised controlled trial.

Cooper DJ, Plewes K, Grigg MJ, Rajahram GS, Piera KA, William T, Chatfield MD, Yeo TW, Dondorp AM, Anstey NM, Barber BE.

Trials. 2018 Apr 24;19(1):250. doi: 10.1186/s13063-018-2600-0.

8.

Acetaminophen as a Renoprotective Adjunctive Treatment in Patients With Severe and Moderately Severe Falciparum Malaria: A Randomized, Controlled, Open-Label Trial.

Plewes K, Kingston HWF, Ghose A, Wattanakul T, Hassan MMU, Haider MS, Dutta PK, Islam MA, Alam S, Jahangir SM, Zahed ASM, Sattar MA, Chowdhury MAH, Herdman MT, Leopold SJ, Ishioka H, Piera KA, Charunwatthana P, Silamut K, Yeo TW, Lee SJ, Mukaka M, Maude RJ, Turner GDH, Faiz MA, Tarning J, Oates JA, Anstey NM, White NJ, Day NPJ, Hossain MA, Roberts Ii LJ, Dondorp AM.

Clin Infect Dis. 2018 Sep 14;67(7):991-999. doi: 10.1093/cid/ciy213.

9.

Effects of Aging on Parasite Biomass, Inflammation, Endothelial Activation, Microvascular Dysfunction and Disease Severity in Plasmodium knowlesi and Plasmodium falciparum Malaria.

Barber BE, Grigg MJ, William T, Piera KA, Boyle MJ, Yeo TW, Anstey NM.

J Infect Dis. 2017 Jun 15;215(12):1908-1917. doi: 10.1093/infdis/jix193.

PMID:
28863470
10.

Plasmacytoid dendritic cells appear inactive during sub-microscopic Plasmodium falciparum blood-stage infection, yet retain their ability to respond to TLR stimulation.

Loughland JR, Minigo G, Sarovich DS, Field M, Tipping PE, Montes de Oca M, Piera KA, Amante FH, Barber BE, Grigg MJ, William T, Good MF, Doolan DL, Engwerda CR, Anstey NM, McCarthy JS, Woodberry T.

Sci Rep. 2017 Jun 1;7(1):2596. doi: 10.1038/s41598-017-02096-2.

11.

Cell-free hemoglobin mediated oxidative stress is associated with acute kidney injury and renal replacement therapy in severe falciparum malaria: an observational study.

Plewes K, Kingston HWF, Ghose A, Maude RJ, Herdman MT, Leopold SJ, Ishioka H, Hasan MMU, Haider MS, Alam S, Piera KA, Charunwatthana P, Silamut K, Yeo TW, Faiz MA, Lee SJ, Mukaka M, Turner GDH, Anstey NM, Jackson Roberts L 2nd, White NJ, Day NPJ, Hossain MA, Dondorp AM.

BMC Infect Dis. 2017 Apr 27;17(1):313. doi: 10.1186/s12879-017-2373-1.

12.

Early Immune Regulatory Changes in a Primary Controlled Human Plasmodium vivax Infection: CD1c+ Myeloid Dendritic Cell Maturation Arrest, Induction of the Kynurenine Pathway, and Regulatory T Cell Activation.

Woodberry T, Loughland JR, Minigo G, Burel JG, Amante FH, Piera KA, McNeil Y, Yeo TW, Good MF, Doolan DL, Engwerda CR, McCarthy JS, Anstey NM.

Infect Immun. 2017 May 23;85(6). pii: e00986-16. doi: 10.1128/IAI.00986-16. Print 2017 Jun.

13.

Detection of Plasmodium knowlesi, Plasmodium falciparum and Plasmodium vivax using loop-mediated isothermal amplification (LAMP) in a co-endemic area in Malaysia.

Piera KA, Aziz A, William T, Bell D, González IJ, Barber BE, Anstey NM, Grigg MJ.

Malar J. 2017 Jan 13;16(1):29. doi: 10.1186/s12936-016-1676-9.

14.

Nitric Oxide-Dependent Endothelial Dysfunction and Reduced Arginine Bioavailability in Plasmodium vivax Malaria but No Greater Increase in Intravascular Hemolysis in Severe Disease.

Barber BE, William T, Grigg MJ, Piera KA, Chen Y, Wang H, Weinberg JB, Yeo TW, Anstey NM.

J Infect Dis. 2016 Nov 15;214(10):1557-1564. Epub 2016 Sep 13.

PMID:
27630198
15.

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection.

Kho S, Marfurt J, Handayuni I, Pava Z, Noviyanti R, Kusuma A, Piera KA, Burdam FH, Kenangalem E, Lampah DA, Engwerda CR, Poespoprodjo JR, Price RN, Anstey NM, Minigo G, Woodberry T.

Malar J. 2016 Jun 21;15:328. doi: 10.1186/s12936-016-1382-7.

16.

Asymmetric Dimethylarginine in Adult Falciparum Malaria: Relationships With Disease Severity, Antimalarial Treatment, Hemolysis, and Inflammation.

Barber BE, William T, Grigg MJ, Parameswaran U, Piera KA, Yeo TW, Anstey NM.

Open Forum Infect Dis. 2016 Feb 9;3(1):ofw027. doi: 10.1093/ofid/ofw027. eCollection 2016 Jan.

17.

Dihydrofolate-Reductase Mutations in Plasmodium knowlesi Appear Unrelated to Selective Drug Pressure from Putative Human-To-Human Transmission in Sabah, Malaysia.

Grigg MJ, Barber BE, Marfurt J, Imwong M, William T, Bird E, Piera KA, Aziz A, Boonyuen U, Drakeley CJ, Cox J, White NJ, Cheng Q, Yeo TW, Auburn S, Anstey NM.

PLoS One. 2016 Mar 1;11(3):e0149519. doi: 10.1371/journal.pone.0149519. eCollection 2016.

18.

Profoundly Reduced CD1c+ Myeloid Dendritic Cell HLA-DR and CD86 Expression and Increased Tumor Necrosis Factor Production in Experimental Human Blood-Stage Malaria Infection.

Loughland JR, Minigo G, Burel J, Tipping PE, Piera KA, Amante FH, Engwerda CR, Good MF, Doolan DL, Anstey NM, McCarthy JS, Woodberry T.

Infect Immun. 2016 Apr 22;84(5):1403-1412. doi: 10.1128/IAI.01522-15. Print 2016 May.

19.

Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection.

Kho S, Marfurt J, Noviyanti R, Kusuma A, Piera KA, Burdam FH, Kenangalem E, Lampah DA, Engwerda CR, Poespoprodjo JR, Price RN, Anstey NM, Minigo G, Woodberry T.

Infect Immun. 2015 Aug;83(8):3224-32. doi: 10.1128/IAI.00226-15. Epub 2015 Jun 1.

20.

Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria.

Barber BE, William T, Grigg MJ, Parameswaran U, Piera KA, Price RN, Yeo TW, Anstey NM.

PLoS Pathog. 2015 Jan 8;11(1):e1004558. doi: 10.1371/journal.ppat.1004558. eCollection 2015 Jan.

21.

Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients.

Darcy CJ, Minigo G, Piera KA, Davis JS, McNeil YR, Chen Y, Volkheimer AD, Weinberg JB, Anstey NM, Woodberry T.

Crit Care. 2014 Aug 1;18(4):R163. doi: 10.1186/cc14003.

22.

Quantification of Plasmodium falciparum histidine-rich protein-2 in cerebrospinal spinal fluid from cerebral malaria patients.

Mikita K, Thakur K, Anstey NM, Piera KA, Pardo CA, Weinberg JB, Mukemba J, Florence S, Mwaikambo ED, Granger DL, Sullivan DJ.

Am J Trop Med Hyg. 2014 Sep;91(3):486-92. doi: 10.4269/ajtmh.14-0210. Epub 2014 Jun 30.

23.

Increased plasma arginase activity in human sepsis: association with increased circulating neutrophils.

Darcy CJ, Woodberry T, Davis JS, Piera KA, McNeil YR, Chen Y, Yeo TW, Weinberg JB, Anstey NM.

Clin Chem Lab Med. 2014 Apr;52(4):573-81. doi: 10.1515/cclm-2013-0698.

24.

Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.

Marfurt J, Chalfein F, Prayoga P, Wabiser F, Wirjanata G, Sebayang B, Piera KA, Wittlin S, Haynes RK, Möhrle JJ, Anstey NM, Kenangalem E, Price RN.

Antimicrob Agents Chemother. 2012 Oct;56(10):5258-63. doi: 10.1128/AAC.00283-12. Epub 2012 Jul 30.

25.

Low-level Plasmodium falciparum blood-stage infection causes dendritic cell apoptosis and dysfunction in healthy volunteers.

Woodberry T, Minigo G, Piera KA, Amante FH, Pinzon-Charry A, Good MF, Lopez JA, Engwerda CR, McCarthy JS, Anstey NM.

J Infect Dis. 2012 Aug 1;206(3):333-40. doi: 10.1093/infdis/jis366. Epub 2012 May 21.

PMID:
22615323
26.

Plasma Plasmodium falciparum histidine-rich protein-2 concentrations are associated with malaria severity and mortality in Tanzanian children.

Rubach MP, Mukemba J, Florence S, John B, Crookston B, Lopansri BK, Yeo TW, Piera KA, Alder SC, Weinberg JB, Anstey NM, Granger DL, Mwaikambo ED.

PLoS One. 2012;7(5):e35985. doi: 10.1371/journal.pone.0035985. Epub 2012 May 7.

27.

Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.

Marfurt J, Chalfein F, Prayoga P, Wabiser F, Kenangalem E, Piera KA, Machunter B, Tjitra E, Anstey NM, Price RN.

Antimicrob Agents Chemother. 2011 Sep;55(9):4461-4. doi: 10.1128/AAC.01375-10. Epub 2011 Jul 5.

28.

Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria.

Salwati E, Minigo G, Woodberry T, Piera KA, de Silva HD, Kenangalem E, Tjitra E, Coppel RL, Price RN, Anstey NM, Plebanski M.

J Infect Dis. 2011 Apr 15;203(8):1192-1199. doi: 10.1093/infdis/jiq166.

29.

Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.

Marfurt J, Chalfein F, Prayoga P, Wabiser F, Kenangalem E, Piera KA, Fairlie DP, Tjitra E, Anstey NM, Andrews KT, Price RN.

Antimicrob Agents Chemother. 2011 Mar;55(3):961-6. doi: 10.1128/AAC.01220-10. Epub 2010 Dec 6.

30.

A study of the TNF/LTA/LTB locus and susceptibility to severe malaria in highland papuan children and adults.

Randall LM, Kenangalem E, Lampah DA, Tjitra E, Mwaikambo ED, Handojo T, Piera KA, Zhao ZZ, de Labastida Rivera F, Zhou Y, McSweeney KM, Le L, Amante FH, Haque A, Stanley AC, Woodberry T, Salwati E, Granger DL, Hobbs MR, Price RN, Weinberg JB, Montgomery GW, Anstey NM, Engwerda CR.

Malar J. 2010 Oct 29;9:302. doi: 10.1186/1475-2875-9-302.

31.

In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia.

Siswantoro H, Russell B, Ratcliff A, Prasetyorini B, Chalfein F, Marfurt J, Kenangalem E, Wuwung M, Piera KA, Ebsworth EP, Anstey NM, Tjitra E, Price RN.

Antimicrob Agents Chemother. 2011 Jan;55(1):197-202. doi: 10.1128/AAC.01122-10. Epub 2010 Oct 11.

32.

In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.

Price RN, Marfurt J, Chalfein F, Kenangalem E, Piera KA, Tjitra E, Anstey NM, Russell B.

Antimicrob Agents Chemother. 2010 Dec;54(12):5146-50. doi: 10.1128/AAC.00801-10. Epub 2010 Sep 27.

33.

Age-related susceptibility to severe malaria associated with galectin-2 in highland Papuans.

Randall LM, Kenangalem E, Lampah DA, Tjitra E, Mwaikambo ED, Handojo T, Piera KA, Zhao ZZ, de Labastida Rivera F, Zhou Y, McSweeney KM, Le L, Amante FH, Haque A, Stanley AC, Woodberry T, Salwati E, Granger DL, Hobbs MR, Price RN, Weinberg JB, Montgomery GW, Anstey NM, Engwerda CR.

J Infect Dis. 2010 Jul 1;202(1):117-24. doi: 10.1086/653125.

34.

Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity.

Davis JS, Yeo TW, Piera KA, Woodberry T, Celermajer DS, Stephens DP, Anstey NM.

Crit Care. 2010;14(3):R89. doi: 10.1186/cc9020. Epub 2010 May 18.

35.

Human T cell recognition of the blood stage antigen Plasmodium hypoxanthine guanine xanthine phosphoribosyl transferase (HGXPRT) in acute malaria.

Woodberry T, Pinzon-Charry A, Piera KA, Panpisutchai Y, Engwerda CR, Doolan DL, Salwati E, Kenangalem E, Tjitra E, Price RN, Good MF, Anstey NM.

Malar J. 2009 Jun 7;8:122. doi: 10.1186/1475-2875-8-122.

36.

Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria.

Minigo G, Woodberry T, Piera KA, Salwati E, Tjitra E, Kenangalem E, Price RN, Engwerda CR, Anstey NM, Plebanski M.

PLoS Pathog. 2009 Apr;5(4):e1000402. doi: 10.1371/journal.ppat.1000402. Epub 2009 Apr 24.

37.

In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.

Hasugian AR, Tjitra E, Ratcliff A, Siswantoro H, Kenangalem E, Wuwung RM, Purba HL, Piera KA, Chalfien F, Marfurt J, Penttinen PM, Russell B, Anstey NM, Price RN.

Antimicrob Agents Chemother. 2009 Mar;53(3):1094-9. doi: 10.1128/AAC.01511-08. Epub 2008 Dec 22.

38.

Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax.

Suwanarusk R, Chavchich M, Russell B, Jaidee A, Chalfein F, Barends M, Prasetyorini B, Kenangalem E, Piera KA, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN.

J Infect Dis. 2008 Nov 15;198(10):1558-64. doi: 10.1086/592451.

39.

Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses.

Woodberry T, Minigo G, Piera KA, Hanley JC, de Silva HD, Salwati E, Kenangalem E, Tjitra E, Coppel RL, Price RN, Anstey NM, Plebanski M.

J Infect Dis. 2008 Jul 1;198(1):134-42. doi: 10.1086/588711.

40.

Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.

Lek-Uthai U, Suwanarusk R, Ruengweerayut R, Skinner-Adams TS, Nosten F, Gardiner DL, Boonma P, Piera KA, Andrews KT, Machunter B, McCarthy JS, Anstey NM, Price RN, Russell B.

Antimicrob Agents Chemother. 2008 Jul;52(7):2435-41. doi: 10.1128/AAC.00169-08. Epub 2008 Apr 28.

41.

Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.

Suwanarusk R, Russell B, Chavchich M, Chalfein F, Kenangalem E, Kosaisavee V, Prasetyorini B, Piera KA, Barends M, Brockman A, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN.

PLoS One. 2007 Oct 31;2(10):e1089.

Supplemental Content

Loading ...
Support Center